Logo image of BLDE

BLADE AIR MOBILITY INC (BLDE) Stock Fundamental Analysis

NASDAQ:BLDE - Nasdaq - US0926671043 - Common Stock - Currency: USD

3.77  -0.1 (-2.58%)

After market: 3.74 -0.03 (-0.8%)

Fundamental Rating

4

Overall BLDE gets a fundamental rating of 4 out of 10. We evaluated BLDE against 22 industry peers in the Passenger Airlines industry. No worries on liquidiy or solvency for BLDE as it has an excellent financial health rating, but there are worries on the profitability. BLDE is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year BLDE has reported negative net income.
In the past year BLDE had a positive cash flow from operations.
BLDE had negative earnings in each of the past 5 years.
In the past 5 years BLDE always reported negative operating cash flow.
BLDE Yearly Net Income VS EBIT VS OCF VS FCFBLDE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -10.60%, BLDE is doing worse than 68.18% of the companies in the same industry.
With a Return On Equity value of -12.09%, BLDE perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -10.6%
ROE -12.09%
ROIC N/A
ROA(3y)-12.68%
ROA(5y)-33.09%
ROE(3y)-15.39%
ROE(5y)-48.99%
ROIC(3y)N/A
ROIC(5y)N/A
BLDE Yearly ROA, ROE, ROICBLDE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

The Gross Margin of BLDE (25.05%) is worse than 68.18% of its industry peers.
In the last couple of years the Gross Margin of BLDE has grown nicely.
BLDE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.59%
GM growth 5YN/A
BLDE Yearly Profit, Operating, Gross MarginsBLDE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

8

2. Health

2.1 Basic Checks

BLDE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BLDE has more shares outstanding
The number of shares outstanding for BLDE has been increased compared to 5 years ago.
BLDE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BLDE Yearly Shares OutstandingBLDE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
BLDE Yearly Total Debt VS Total AssetsBLDE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 6.25 indicates that BLDE is not in any danger for bankruptcy at the moment.
The Altman-Z score of BLDE (6.25) is better than 95.45% of its industry peers.
There is no outstanding debt for BLDE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.25
ROIC/WACCN/A
WACC9.17%
BLDE Yearly LT Debt VS Equity VS FCFBLDE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

BLDE has a Current Ratio of 6.96. This indicates that BLDE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BLDE (6.96) is better than 95.45% of its industry peers.
BLDE has a Quick Ratio of 6.96. This indicates that BLDE is financially healthy and has no problem in meeting its short term obligations.
BLDE's Quick ratio of 6.96 is amongst the best of the industry. BLDE outperforms 95.45% of its industry peers.
Industry RankSector Rank
Current Ratio 6.96
Quick Ratio 6.96
BLDE Yearly Current Assets VS Current LiabilitesBLDE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.12% over the past year.
Looking at the last year, BLDE shows a quite strong growth in Revenue. The Revenue has grown by 10.44% in the last year.
BLDE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 70.13% yearly.
EPS 1Y (TTM)62.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y70.13%
Revenue growth 5YN/A
Sales Q2Q%4.2%

3.2 Future

The Earnings Per Share is expected to grow by 41.77% on average over the next years. This is a very strong growth
BLDE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.27% yearly.
EPS Next Y69.12%
EPS Next 2Y35.04%
EPS Next 3Y23.63%
EPS Next 5Y41.77%
Revenue Next Year5.36%
Revenue Next 2Y6.84%
Revenue Next 3Y7.65%
Revenue Next 5Y26.27%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BLDE Yearly Revenue VS EstimatesBLDE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
BLDE Yearly EPS VS EstimatesBLDE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

1

4. Valuation

4.1 Price/Earnings Ratio

BLDE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BLDE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLDE Price Earnings VS Forward Price EarningsBLDE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLDE Per share dataBLDE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as BLDE's earnings are expected to grow with 23.63% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.04%
EPS Next 3Y23.63%

0

5. Dividend

5.1 Amount

BLDE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLADE AIR MOBILITY INC

NASDAQ:BLDE (8/7/2025, 8:12:47 PM)

After market: 3.74 -0.03 (-0.8%)

3.77

-0.1 (-2.58%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners59.15%
Inst Owner Change0.62%
Ins Owners10.86%
Ins Owner Change3.02%
Market Cap305.45M
Analysts85.45
Price Target7.34 (94.69%)
Short Float %4.29%
Short Ratio3.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.02%
Min EPS beat(2)-24.95%
Max EPS beat(2)64.99%
EPS beat(4)2
Avg EPS beat(4)-16.75%
Min EPS beat(4)-145.1%
Max EPS beat(4)64.99%
EPS beat(8)4
Avg EPS beat(8)-22.37%
EPS beat(12)7
Avg EPS beat(12)-0.26%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.97%
Min Revenue beat(2)4.23%
Max Revenue beat(2)7.7%
Revenue beat(4)3
Avg Revenue beat(4)4.02%
Min Revenue beat(4)-1.39%
Max Revenue beat(4)7.7%
Revenue beat(8)6
Avg Revenue beat(8)3.75%
Revenue beat(12)10
Avg Revenue beat(12)7.23%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)11.11%
EPS NY rev (3m)29.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.96%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.21
P/FCF N/A
P/OCF 23.89
P/B 1.39
P/tB 1.86
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)0.16
OCFY4.19%
SpS3.1
BVpS2.71
TBVpS2.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.6%
ROE -12.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.05%
FCFM N/A
ROA(3y)-12.68%
ROA(5y)-33.09%
ROE(3y)-15.39%
ROE(5y)-48.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.59%
GM growth 5YN/A
F-Score7
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 577.38%
Cap/Sales 13.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.96
Quick Ratio 6.96
Altman-Z 6.25
F-Score7
WACC9.17%
ROIC/WACCN/A
Cap/Depr(3y)198.6%
Cap/Depr(5y)143.5%
Cap/Sales(3y)4.9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y69.12%
EPS Next 2Y35.04%
EPS Next 3Y23.63%
EPS Next 5Y41.77%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y70.13%
Revenue growth 5YN/A
Sales Q2Q%4.2%
Revenue Next Year5.36%
Revenue Next 2Y6.84%
Revenue Next 3Y7.65%
Revenue Next 5Y26.27%
EBIT growth 1Y51.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year130.57%
EBIT Next 3Y41.77%
EBIT Next 5Y38.84%
FCF growth 1Y50.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y129.11%
OCF growth 3YN/A
OCF growth 5YN/A